These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 32735983)

  • 1. New insights in the mode of action of (+)-erythravine and (+)-11α-hydroxy-erythravine alkaloids.
    Gelfuso EA; Reis SL; Aguiar DSR; Faggion SA; Gomes FMM; Galan DT; Peigneur S; Pereira AMS; Mortari MR; Cunha AOS; Tytgat J; Beleboni RO
    Eur J Pharmacol; 2020 Oct; 885():173390. PubMed ID: 32735983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of erythrinian alkaloids isolated from Erythrina mulungu (Papilionaceae) in mice submitted to animal models of anxiety.
    Flausino OA; Pereira AM; da Silva Bolzani V; Nunes-de-Souza RL
    Biol Pharm Bull; 2007 Feb; 30(2):375-8. PubMed ID: 17268084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticonvulsant profile of the alkaloids (+)-erythravine and (+)-11-α-hydroxy-erythravine isolated from the flowers of Erythrina mulungu Mart ex Benth (Leguminosae-Papilionaceae).
    Faggion SA; Cunha AO; Fachim HA; Gavin AS; dos Santos WF; Pereira AM; Beleboni RO
    Epilepsy Behav; 2011 Mar; 20(3):441-6. PubMed ID: 21277832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anxiolytic effects of erythrinian alkaloids from Erythrina mulungu.
    Flausino O; Santos Lde A; Verli H; Pereira AM; Bolzani Vda S; Nunes-de-Souza RL
    J Nat Prod; 2007 Jan; 70(1):48-53. PubMed ID: 17253849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythrina mulungu alkaloids are potent inhibitors of neuronal nicotinic receptor currents in mammalian cells.
    Setti-Perdigão P; Serrano MA; Flausino OA; Bolzani VS; Guimarães MZ; Castro NG
    PLoS One; 2013; 8(12):e82726. PubMed ID: 24349349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective effects and improvement of learning and memory elicited by erythravine and 11α-hydroxy-erythravine against the pilocarpine model of epilepsy.
    Gelfuso EA; Reis SL; Pereira AMS; Aguiar DSR; Beleboni RO
    Life Sci; 2020 Jan; 240():117072. PubMed ID: 31751584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erysothrine, an alkaloid extracted from flowers of Erythrina mulungu Mart. ex Benth: evaluating its anticonvulsant and anxiolytic potential.
    Santos Rosa D; Faggion SA; Gavin AS; Anderson de Souza M; Fachim HA; Ferreira dos Santos W; Soares Pereira AM; Cunha AO; Beleboni RO
    Epilepsy Behav; 2012 Mar; 23(3):205-12. PubMed ID: 22381390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterisation of anticonvulsant effects elicited by erythrartine.
    Dos Reis SL; Gelfuso EA; Fachin AL; Pereira AMS; Beleboni RO
    J Pharm Pharmacol; 2021 Mar; 73(1):93-97. PubMed ID: 33791806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the plant alkaloid tetrandrine on human nicotinic acetylcholine receptors.
    Slater Y; Houlihan LM; Cassels BK; Lukas RJ; Bermúdez I
    Eur J Pharmacol; 2002 Aug; 450(3):213-21. PubMed ID: 12208312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alkaloids indolizidine 235B', quinolizidine 1-epi-207I, and the tricyclic 205B are potent and selective noncompetitive inhibitors of nicotinic acetylcholine receptors.
    Tsuneki H; You Y; Toyooka N; Kagawa S; Kobayashi S; Sasaoka T; Nemoto H; Kimura I; Dani JA
    Mol Pharmacol; 2004 Oct; 66(4):1061-9. PubMed ID: 15258256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylene blue inhibits the function of α7-nicotinic acetylcholine receptors.
    Al Mansouri AS; Lorke DE; Nurulain SM; Ashoor A; Keun-Hang SY; Petroianu G; Isaev D; Oz M
    CNS Neurol Disord Drug Targets; 2012 Sep; 11(6):791-800. PubMed ID: 22483305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BIIR 561 CL: a novel combined antagonist of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors and voltage-dependent sodium channels with anticonvulsive and neuroprotective properties.
    Weiser T; Brenner M; Palluk R; Bechtel WD; Ceci A; Brambilla A; Ensinger HA; Sagrada A; Wienrich M
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1343-9. PubMed ID: 10336525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of pyridine ring substitutions on affinity, efficacy, and subtype selectivity of neuronal nicotinic receptor agonist epibatidine.
    Avalos M; Parker MJ; Maddox FN; Carroll FI; Luetje CW
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1246-52. PubMed ID: 12183686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation and inhibition of neuronal nicotinic receptors by atropine: competitive and noncompetitive effects.
    Zwart R; Vijverberg HP
    Mol Pharmacol; 1997 Nov; 52(5):886-95. PubMed ID: 9351980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reconstitution of synaptic Ion channels from rodent and human brain in Xenopus oocytes: a biochemical and electrophysiological characterization.
    Mazzo F; Zwart R; Serratto GM; Gardinier KM; Porter W; Reel J; Maraula G; Sher E
    J Neurochem; 2016 Aug; 138(3):384-96. PubMed ID: 27216696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diverse actions of neonicotinoids on chicken alpha7, alpha4beta2 and Drosophila-chicken SADbeta2 and ALSbeta2 hybrid nicotinic acetylcholine receptors expressed in Xenopus laevis oocytes.
    Ihara M; Matsuda K; Otake M; Kuwamura M; Shimomura M; Komai K; Akamatsu M; Raymond V; Sattelle DB
    Neuropharmacology; 2003 Jul; 45(1):133-44. PubMed ID: 12814666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does acetaldehyde mediate ethanol action in the central nervous system?
    Mascia MP; Maiya R; Borghese CM; Lobo IA; Hara K; Yamakura T; Gong DH; Beckstead MJ
    Alcohol Clin Exp Res; 2001 Nov; 25(11):1570-5. PubMed ID: 11707631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107.
    Malysz J; Anderson DJ; Grønlien JH; Ji J; Bunnelle WH; Håkerud M; Thorin-Hagene K; Ween H; Helfrich R; Hu M; Gubbins E; Gopalakrishnan S; Puttfarcken PS; Briggs CA; Li J; Meyer MD; Dyhring T; Ahring PK; Nielsen EØ; Peters D; Timmermann DB; Gopalakrishnan M
    J Pharmacol Exp Ther; 2010 Sep; 334(3):863-74. PubMed ID: 20504915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UB-165: a novel nicotinic agonist with subtype selectivity implicates the alpha4beta2* subtype in the modulation of dopamine release from rat striatal synaptosomes.
    Sharples CG; Kaiser S; Soliakov L; Marks MJ; Collins AC; Washburn M; Wright E; Spencer JA; Gallagher T; Whiteaker P; Wonnacott S
    J Neurosci; 2000 Apr; 20(8):2783-91. PubMed ID: 10751429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant nicotinic receptors, expressed in Xenopus oocytes, do not resemble native rat sympathetic ganglion receptors in single-channel behaviour.
    Sivilotti LG; McNeil DK; Lewis TM; Nassar MA; Schoepfer R; Colquhoun D
    J Physiol; 1997 Apr; 500 ( Pt 1)(Pt 1):123-38. PubMed ID: 9097938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.